In last trading session, Climb Bio Inc (NASDAQ:CLYM) saw 0.13 million shares changing hands with its beta currently measuring -0.26. Company’s recent per share price level of $1.87 trading at -$0.22 or -10.53% at ring of the bell on the day assigns it a market valuation of $125.71M. That closing price of CLYM’s stock is at a discount of -517.65% from its 52-week high price of $11.55 and is indicating a premium of 7.49% from its 52-week low price of $1.73. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 0.48 million shares which gives us an average trading volume of 331.12K if we extend that period to 3-months.

Climb Bio Inc (NASDAQ:CLYM) trade information

Upright in the red during last session for losing -10.53%, in the last five days CLYM remained trading in the green while hitting it’s week-highest on Tuesday, 01/07/25 when the stock touched $1.87 price level, adding 20.76% to its value on the day. Climb Bio Inc’s shares saw a change of 3.89% in year-to-date performance and have moved 3.89% in past 5-day. Climb Bio Inc (NASDAQ:CLYM) showed a performance of -38.08% in past 30-days. Number of shares sold short was 4.93 million shares which calculate 23.36 days to cover the short interests.

Climb Bio Inc (CLYM) estimates and forecasts

Statistics highlight that Climb Bio Inc is scoring comparatively lower than the scores of other players of the relevant industry. The company lost -73.92% of value to its shares in past 6 months, showing an annual growth rate of -20.77% while that of industry is 17.00. Apart from that, the company came lowering its revenue forecast for fiscal year 2025.

Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of -46.72% during past 5 years.